Therapeutic design of peptide modulators of protein-protein interactions in membranes

被引:49
|
作者
Stone, Tracy A.
Deber, Charles M.
机构
[1] Hosp Sick Children, Res Inst, Div Mol Struct Funct, Toronto, ON MSG 0A4, Canada
[2] Univ Toronto, Dept Biochem, Toronto, ON MSS 1A8, Canada
来源
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Peptide; Protein-protein interaction (PPI); Transmembrane; Peptidomimetics; Lipidation; Hydrocarbon staple; TRANSMEMBRANE DOMAIN INTERACTIONS; CATIONIC ANTIMICROBIAL PEPTIDES; RECEPTOR TYROSINE KINASE; ACTIVATION IN-VITRO; STAPLED PEPTIDES; BETA-PEPTIDES; COMPUTATIONAL DESIGN; DRIVE ASSOCIATION; FUTURE-DIRECTIONS; DRUG TARGETS;
D O I
10.1016/j.bbamem.2016.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Membrane proteins play the central roles in a variety of cellular processes, ranging from nutrient uptake and signalling, to cell-cell communication. Their biological functions are directly related to how they fold and assemble; defects often lead to disease. Protein-protein interactions (PPIs) within the membrane are therefore of great interest as therapeutic targets. Here we review the progress in the application of membrane-insertable peptides for the disruption or stabilization of membrane-based PPIs. We describe the design and preparation of transmembrane peptide mimics; and of several categories of peptidomimetics used for study, including o-enantiomers, non-natural amino acids, peptoids, and beta-peptides. Further aspects of the review describe modifications to membrane-insertable peptides, including lipidation and cyclization via hydrocarbon stapling. These approaches provide a pathway toward the development of metabolically stable, non-toxic, and efficacious peptide modulators of membrane-based PPIs. This article is part of a Special Issue entitled: Lipid order/lipid defects and lipid control of protein activity edited by Dirk Schneider. (C)2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [31] Peptide modulators of protein–protein interactions in intracellular signaling
    Miriam C. Souroujon
    Daria Mochly-Rosen
    Nature Biotechnology, 1998, 16 : 919 - 924
  • [32] Development of Agents that Modulate Protein-Protein Interactions in Membranes
    Zhao, Tina X.
    Martinko, Alexander J.
    Le, Vy H.
    Zhao, Jing
    Yin, Hang
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (09) : 1055 - 1062
  • [33] Solid state NMR and protein-protein interactions in membranes
    Miao, Yimin
    Cross, Timothy A.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2013, 23 (06) : 919 - 928
  • [34] Interfering with protein-protein contact: Molecular interaction maps and peptide modulators
    Nieddu, Erika
    Pasa, Stefania
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (01) : 21 - 32
  • [35] Peptide-based inhibitors of protein-protein interactions
    Wojcik, Paulina
    Berlicki, Lukasz
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 707 - 713
  • [36] Peptides and Peptide Analogs to Inhibit Protein-Protein Interactions
    Helmer, Dorothea
    Schmitz, Katja
    PROTEIN TARGETING COMPOUNDS: PREDICTION, SELECTION AND ACTIVITY OF SPECIFIC INHIBITORS, 2016, 917 : 147 - 183
  • [37] Studying protein-protein interactions using peptide arrays
    Katz, Chen
    Levy-Beladev, Liron
    Rotem-Bamberger, Shahar
    Rito, Tiago
    Rudiger, Stefan G. D.
    Friedler, Assaf
    CHEMICAL SOCIETY REVIEWS, 2011, 40 (05) : 2131 - 2145
  • [38] Exploring Protein-Protein Interactions with Synthetic Peptide Arrays
    Volkmer, Rudolf
    Tapia, Victor
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2011, 8 (02) : 164 - 170
  • [39] Designing helical peptide inhibitors of protein-protein interactions
    Araghi, Raheleh Rezaei
    Keating, Amy E.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2016, 39 : 27 - 38
  • [40] Exploring protein-protein interactions by peptide docking protocols
    Weng, GZ
    G PROTEIN PATHWAYS PART B: G PROTEINS AND THEIR REGULATORS, 2002, 344 : 577 - 586